Search

everythinglearnresearchcommunity

for

Search:↓

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Blocking interferon-gamma might help treat various autoimmune diseases.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

HHORSC exosomes and PL improve hair growth treatment outcomes.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.